Randomized trial · people

Cerebrolysin: better arm function at day 90 after stroke in CARS

Checked against the paper Randomized trialPublished by PepVault

The takeaway

One placebo-controlled trial found better arm recovery after stroke when Cerebrolysin was added to early rehab, but it was exploratory and still needs a larger trial to confirm it.

Kind
Randomized trial
Studied in
People
Published
2016
Journal
Stroke

What they tested

The team tested whether stroke patients given Cerebrolysin had better arm and hand movement at day 90 than patients given a placebo.

How the study was done

A randomized, double-blind, placebo-controlled phase II trial at several centers, in patients who had just had a stroke. They got Cerebrolysin (30 mL/d) or saline placebo once a day for 21 days, starting 24 to 72 hours after the stroke, and all joined a standard 21-day rehab program.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

At day 90, the Cerebrolysin group scored higher than the placebo group on the Action Research Arm Test, a measure of arm and hand use. The team rated this a large advantage, with an effect size (a Mann-Whitney estimator) of 0.71 and a 95% confidence interval running from 0.63 to 0.79 (P<0.0001). When 12 outcome scales of overall status were combined, Cerebrolysin came out ahead by a small-to-medium margin, with an estimator of 0.62 (95% confidence interval from 0.58 to 0.65, P<0.0001). Only 3.8% of patients dropped out early, and safety was similar to placebo.

What it doesn’t show

This was an exploratory trial with a fairly small number of patients, so the team says a large trial is needed to confirm it. All patients started treatment within days of the stroke alongside rehab, so it does not show effects in later stroke recovery or without rehab.

The paper

Muresanu et al. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke. 2016.

The compound

More studies on Cerebrolysin

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo